Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | 65,767 | reported | 20 May 2022 | tx 23+490,017−50,000 |
| LIGAND PHARMACEUTICALS INC | 17,667 | reported | 12 Feb 2014 | tx 67+616,277−198,053 |
| SEQUENOM INC | 3,219 | reported | 18 Jan 2007 | tx 2+28,219 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 6,026 | 0.68 USD | |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 115,500 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 24,750 | 0.00 USD | deriv |
| 19 Nov 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 2,017 | 2.01 USD | |
| 03 Nov 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 7,500 | 1.68 USD | |
| 03 Nov 2021 | EXERCISE | PhaseBio Pharmaceuticals Inc | 7,500 | 1.68 USD | deriv |
| 03 Aug 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 7,500 | 1.68 USD | |
| 20 May 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1,419 | 2.80 USD | |
| 05 Feb 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 76,500 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1,305 | 3.00 USD | |
| 14 Aug 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,000 | 1.69 USD | |
| 14 Aug 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,000 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 100,000 | 0.00 USD | deriv |
| 21 Aug 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 10,000 | 1.69 USD | |
| 21 Aug 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,000 | 1.44 USD | |
| 21 Aug 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 10,000 | 0.00 USD | deriv |
| 21 Aug 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,000 | 0.00 USD | deriv |
| 22 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 15,000 | 1.69 USD | |
| 22 May 2019 | EXERCISE | PhaseBio Pharmaceuticals Inc | 15,000 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 100,000 | 0.00 USD | deriv |
| 07 Dec 2018 | PURCHASE | PhaseBio Pharmaceuticals Inc | 5,000 | 3.84 USD | |
| 12 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 7,321 | 74.27 USD | |
| 12 Feb 2014 | EXERCISE | LIGAND PHARMACEUTICALS INC | 6,012 | 21.00 USD | |
| 12 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 6,012 | 75.73 USD | |
| 12 Feb 2014 | EXERCISE | LIGAND PHARMACEUTICALS INC | 6,086 | 10.05 USD |